companydata.dkcompanydata.dk

2CARE4 ApS: Financial statements 2025

CVR: 28964080

Source: annual report 2025, Danish Business Authority

01/01/202531/12/2025

2CARE4 ApS (CVR 28964080) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 1,500,005,000 and a net result of DKK 16,975,000 compared with DKK 20,347,000 the year before. That is an increase of 21.9% compared with the year before. The profit margin was 1.1%. Equity in the 2025 report amounted to DKK 46,406,000. The solvency ratio was 9.2%. The company had 160 employees in the financial year.

Revenue
DKK 1,500,005,000
Gross Profit
DKK 138,963,000
Profit/Loss
DKK 16,975,000
Equity
DKK 46,406,000
Total Assets
DKK 506,680,000
Employees
160

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20251.5 mia.139 mio.17 mio.46.4 mio.160
20241.2 mia.136.3 mio.20.3 mio.100.1 mio.110
20231.2 mia.162.4 mio.48.8 mio.104.7 mio.108
20221.2 mia.132.6 mio.33.7 mio.75.1 mio.118
2021830 mio.53.3 mio.-21.3 mio.41.5 mio.102

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is 2CARE4 ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

2CARE4 ApS wins public contractDec 23, 2025

2CARE4 ApS has won the tender "Amgros 2026 1.450.b" issued by Amgros I/S worth 72,960,000 DKK.

Henrik Bisgaard Jensen leaves the board of 2CARE4 ApSDec 16, 2025

As of December 16, 2025, Henrik Bisgaard Jensen has left the board of directors of 2CARE4 ApS.

Thomas Hjarsbæk Rasmussen steps down as director of 2CARE4 ApSDec 1, 2025

As of December 1, 2025, Thomas Hjarsbæk Rasmussen has stepped down as director of 2CARE4 ApS.

2CARE4 ApS wins public contractNov 14, 2025

2CARE4 ApS has won the tender "Amgros 2026 1.601.a" issued by Amgros I/S worth 331,750,548 DKK.

2CARE4 ApS wins public contractNov 7, 2025

2CARE4 ApS has won the tender "Amgros 2026 1.1201.a" issued by Amgros I/S worth 358,514,920 DKK.

2CARE4 ApS wins public contractOct 31, 2025

2CARE4 ApS has won the tender "Amgros 2026 2.1302.b" issued by Amgros I/S worth 161,990,275 DKK.

2CARE4 ApS wins public contractOct 31, 2025

2CARE4 ApS has won the tender "Amgros 2026 2.1390.b" issued by Amgros I/S worth 23,945,273 DKK.

2CARE4 ApS wins public contractOct 30, 2025

2CARE4 ApS has won the tender "Amgros 2026 1.603.a" issued by Amgros I/S worth 7,867,813 DKK.

2CARE4 ApS wins public contractOct 30, 2025

2CARE4 ApS has won the tender "Amgros 2026 1.615.b" issued by Amgros I/S worth 48,195,968 DKK.

2CARE4 ApS wins public contractOct 29, 2025

2CARE4 ApS has won the tender "Amgros 2026 1.1203.a" issued by Amgros I/S worth 368,505,024 DKK.

About 2CARE4 ApS

2CARE4 ApS is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2005. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Erik Sandberg. The board consists of Toke Værndal. The company is owned by 2care4 Group ApS. The company has 89 employees (2018). In 2025, the company reported revenue of DKK 1,500,005,000 and a net result of DKK 16,975,000 compared with DKK 20,347,000 the year before. Equity in the 2025 report amounted to DKK 46,406,000.

Source: annual report 2025, Danish Business Authority